Event Highlights
Plant Tours - 12 March 2013 (PM)
In the afternoon of day one, delegates will have the opportunity to visit one of three state-of-the art
sites to see in action the concepts presented during the different sessions.
(Places are limited for each site and will be allocated on a first-come, first-served basis)
Take Back to Your Job:
- View world-class facilities
- Share best practice and knowledge
- Network with colleagues
- Benchmark your own operations
Novo Nordisk A/S
Gentofte, Denmark
Novo Nordisk is a healthcare company and a world leader in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society.
H. Lundbeck A/S
Copenhagen Valby, Denmark
H. Lundbeck A/S is an international pharmaceutical company engaged in the research and development,
production, marketing and sale of drugs for the treatment of psychiatric and neurological disorders.
Lundbeck aims to continue to develop new and innovative pharmaceuticals to help people who suffer from CNS
(central nervous system) diseases. The ISPE plant tour will include an overview of Lundbeck, our innovative
pharmaceutical products and our production.
Statens Serum Institut (SSI)
Copenhagen, Denmark
Statens Serum Institut (SSI) is responsible for research-based health surveillance, rational use of IT in
the Danish healthcare system and prevention and control of infectious diseases, biological threats and
congenital disorders.
SSI is a public enterprise under the Danish Ministry of Health. For more than 100 years SSI’s main task has
been to secure the preparedness towards infectious diseases and congenital disorders. The tasks have been
expanded, and today, SSI is an international research, production and service enterprise. SSI aims to ensure
advanced control of infectious diseases, including new infections and biological threats. The Institute also
strives to be a highly regarded and recognised national and international research, production and service
enterprise.
Agenda - Tuesday, 12 March PM
Coaches for the plant venues will depart from the Congress venue at 15h00, and are expected to return at
18h00.
Thank you to our Top Tier Sponsors
Follow ISPE